使用深度学习开发和验证松芽细胞瘤患者的生存预测模型:基于SEER的研究
Xuanzi Li1, Shuai Yang2, Yingpeng Peng1
1The Cancer Center, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guang dong Province, China.
Cancer reports (Hoboken, N.J.)
|August 7, 2025
概括
深度学习模型准确地预测了松芽细胞瘤患者的3年生存期,超过了传统的Cox比例危险模型. 这一进步为这种罕见的中枢神经系统瘤提供了更好的预后见解.
科学领域:
- 神经瘤学神经瘤学
- 计算生物学是一种计算生物学.
- 医学数据科学 医学数据科学
背景情况:
- 松芽细胞瘤 (PBs) 是罕见的儿科中枢神经系统瘤,预后数据有限.
- 缺少PB生存结果的现有预测模型.
- 准确的预后对于指导治疗和管理患者期望至关重要.
研究的目的:
- 开发和验证深度学习 (DL) 模型,用于预测松叶母细胞瘤患者的3年总生存率 (OS) 和疾病特异性生存率 (DSS).
- 将DL模型的预测性能与传统的Cox比例危险 (CPH) 模型进行比较.
主要方法:
- 从监测,流行病学和最终结果 (SEER) 数据库 (1975-2019) 中确定了被诊断患有松芽细胞瘤的患者.
- 深度神经网络 (DNN) 被训练并使用5倍交叉验证进行测试.
- 为了进行比较分析,构建了多变量CPH模型. 模型性能使用ROC曲线分析和校准图进行评估.
主要成果:
- 这项研究包括145名患有松芽细胞瘤的患者.
- DNN模型在3年后的OS (AUC=0.92) 和DSS (AUC=0.76) 中实现了高预测准确度.
- 开发的DNN模型证明了OS和DSS预测的良好校准.
结论:
- 与CPH模型相比,深度学习模型显著提高了松芽细胞瘤患者生存结果的预测准确性.
- 这些发现突显了DL算法在改善罕见瘤类型的预后能力方面的潜力.
- 开发的DL模型可以帮助更好地预测细胞瘤的结果和临床决策.
更多相关视频
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.9K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
相关概念视频
Survival Tree
160
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
160
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
